Albemarle Corporation (LON:0HC7)
London · Delayed Price · Currency is GBP · Price in USD | Market Cap | 17.53B +235.9% |
| Revenue (ttm) | 4.16B +7.9% |
| Net Income | -302.65M |
| EPS | -2.57 |
| Shares Out | n/a |
| PE Ratio | n/a |
| Forward PE | 15.92 |
| Dividend | 1.21 (0.60%) |
| Ex-Dividend Date | Mar 13, 2026 |
| Volume | 1,926 |
| Average Volume | 5,980 |
| Open | 206.35 |
| Previous Close | 206.39 |
| Day's Range | 196.41 - 212.00 |
| 52-Week Range | 53.83 - 221.10 |
| Beta | 1.37 |
| RSI | 55.42 |
| Earnings Date | May 6, 2026 |
About Albemarle
Albemarle Corporation provides energy storage solutions worldwide. It operates through three segments: Energy Storage, Specialties, and Ketjen. The Energy Storage segment offers lithium compounds, including lithium carbonate, lithium hydroxide, and lithium chloride for use in lithium batteries used in consumer electronics and electric vehicles, power grids and solar panels, high performance greases, specialty glass used in consumer appliances and electronics. The Specialties segment provides bromine and highly specialized lithium solutions for ... [Read more]
Financial Performance
In 2025, Albemarle's revenue was $5.14 billion, a decrease of -4.37% compared to the previous year's $5.38 billion. Losses were -$677.38 million, -48.53% less than in 2024.
Financial numbers in USD Financial StatementsNews
Albemarle price target raised to $250 from $210 at Deutsche Bank
Deutsche Bank analyst David Begleiter raised the firm’s price target on Albemarle (ALB) to $250 from $210 and keeps a Buy rating on the shares. The firm believes higher lithium…
Albemarle price target raised to $253 from $245 at RBC Capital
RBC Capital raised the firm’s price target on Albemarle (ALB) to $253 from $245 and keeps an Outperform rating on the shares. The company posted a strong Q1 beat and…
Albemarle price target raised to $230 from $185 at Argus
Argus raised the firm’s price target on Albemarle (ALB) to $230 from $185 and keeps a Buy rating on the shares. The company’s results are linked closely to pricing trends…
Albemarle price target raised to $264 from $230 at UBS
UBS raised the firm’s price target on Albemarle (ALB) to $264 from $230 and keeps a Buy rating on the shares.
Albemarle price target raised to $236 from $210 at Baird
Baird raised the firm’s price target on Albemarle (ALB) to $236 from $210 and keeps a Neutral rating on the shares. The firm updated its model following Q1 results. Published…
Albemarle price target raised to $260 from $245 at Truist
Truist raised the firm’s price target on Albemarle (ALB) to $260 from $245 and keeps a Buy rating on the shares after its Q1 results. Energy Storage earnings are significantly…
Albemarle price target raised to $225 from $210 at Citi
Citi raised the firm’s price target on Albemarle (ALB) to $225 from $210 and keeps a Neutral rating on the shares.
Early notable gainers among liquid option names on May 7th
Notable gainers among liquid option names this morning include Datadog (DDOG) $183.80 +40.09, Fortinet (FTNT) $111.13 +21.18, Albemarle (ALB) $219.81 +27.20, Axon Enterprise (AXON) $421.45 +35.59, and...
Lithium Giant Runs Wild, But 2 Patterns Bear Watching
On Wednesday evening, lithium-producing giant Albemarle ($ALB) released its first-quarter financial results. For the period ended March 31, Albemarle posted adjusted EPS of $2.95 and GAAP EPS of $2.34...
Albemarle price target raised to $205 from $185 at Mizuho
Mizuho raised the firm’s price target on Albemarle (ALB) to $205 from $185 and keeps a Neutral rating on the shares.
Albemarle Earnings Call Transcript: Q1 2026
Q1 2026 saw net sales rise 33% and adjusted EBITDA more than double, driven by strong lithium and specialties demand, higher pricing, and operational improvements. Debt repayment and productivity gains strengthened the balance sheet, while guidance for specialties was raised amid resilient end markets.
Albemarle reports Q1 adjusted EPS $2.95 vs. (18c) last year
Reports Q1 revenue $1.4B, consensus $1.32B. “Albemarle (ALB) had a strong start to 2026, with net sales and adjusted EBITDA up year over year. Higher pricing and volumes in Energy…
Albemarle sees FY26 CapEx $550M-$600M
16:20 EDT Albemarle (ALB) sees FY26 CapEx $550M-$600M
Albemarle Reports First Quarter 2026 Results
CHARLOTTE, N.C., May 6, 2026 /PRNewswire/ -- Albemarle Corporation (NYSE: ALB), a global leader in providing essential elements for mobility, energy, connectivity and health, today announced its resul...
Albemarle Announces Quarterly Common Stock Dividend
CHARLOTTE, N.C., May 5, 2026 /PRNewswire/ -- The Board of Directors of Albemarle Corporation (NYSE: ALB) today announced that it declared a quarterly common stock dividend of $0.405 per share.
Albemarle price target raised to $245 from $216 at RBC Capital
RBC Capital raised the firm’s price target on Albemarle (ALB) to $245 from $216 and keeps an Outperform rating on the shares as part of a broader research note previewing…
Albemarle price target raised to $245 from $210 at Truist
Truist raised the firm’s price target on Albemarle (ALB) to $245 from $210 and keeps a Buy rating on the shares. Lithium pricing strength has continued throughout 2026 and the…
Albemarle downgraded to Neutral from Buy at Rothschild & Co Redburn
Rothschild & Co Redburn downgraded Albemarle (ALB) to Neutral from Buy with a price target of $188, up from $185. The firm’s updated lithium supply/demand analysis indicates that overproduction in…
Albemarle price target raised to $225 from $190 at BofA
BofA raised the firm’s price target on Albemarle (ALB) to $225 from $190 and keeps a Buy rating on the shares. Commodity markets inflated rapidly through March and into April…
Albemarle price target raised to $210 from $190 at Citi
Citi analyst Patrick Cunningham raised the firm’s price target on Albemarle (ALB) to $210 from $190 and keeps a Neutral rating on the shares as part of a Q1 preview.
Albemarle Had Its Best Day Since 2023. The Lithium Stock Gets Downgraded Anyway.
Albemarle has been a strong performer but lithium pricing and valuation risks remain, Baird says.
Albemarle downgraded to Neutral from Outperform at Baird
Baird downgraded Albemarle (ALB) to Neutral from Outperform with an unchanged price target of $210. The firm cites valuation for the downgrade with the shares up 47% year-to-date. The analyst…
Early notable gainers among liquid option names on April 16th
Notable gainers among liquid option names this morning include Lumentum (LITE) $872.45 +48.44, Albemarle (ALB) $196.22 +10.84, ON Semiconductor (ON) $76.62 +4.19, PPG Industries (PPG) $113.59 +5.88, a...